Literature DB >> 27239786

Tumorigenic Properties of Drosophila Epithelial Cells Mutant for lethal giant larvae.

Manuel Calleja1, Ginés Morata1, Jordi Casanova2,3.   

Abstract

BACKGROUND: Mutations in Drosophila tumor suppressor genes (TSGs) lead to the formation of invasive tumors in the brain and imaginal discs.
RESULTS: Here we studied the tumorigenic properties of imaginal discs mutant for the TSG gene lethal giant larvae (lgl). lgl mutant cells display the characteristic features of mammalian tumor cells: they can proliferate indefinitely, induce additional tracheogenesis (an insect counterpart of vasculogenesis) and invade neighboring tissues. Lgl mutant tissues exhibit high apoptotic levels, which lead to the activation of the Jun-N-Terminal Kinase (JNK) pathway. We propose that JNK is a key factor in the acquisition of these tumorigenic properties; it promotes cell proliferation and induces high levels of Mmp1 and confers tumor cells capacity to invade wild-type tissue. Noteworthy, lgl RNAi-mediated down-regulation does not produce similar transformations in the central nervous system (CNS), thereby indicating a fundamental difference between the cells of developing imaginal discs and those of differentiated organs. We discuss these results in the light of the "single big-hit origin" of some human pediatric or developmental cancers.
CONCLUSIONS: Down-regulation of lgl in imaginal discs is sufficient to enhance tracheogenesis and to promote invasion and colonization of other larval structures including the CNS. Developmental Dynamics 245:834-843, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Drosophila tumors; JNK activity; apoptosis; lethal giant larvae; massive overgrowths; pediatric cancers; tracheogenesis and invasiveness

Mesh:

Substances:

Year:  2016        PMID: 27239786     DOI: 10.1002/dvdy.24420

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  8 in total

1.  Over-expression of Hsp83 in grossly depleted hsrω lncRNA background causes synthetic lethality and l(2)gl phenocopy in Drosophila.

Authors:  Mukulika Ray; Sundaram Acharya; Sakshi Shambhavi; Subhash C Lakhotia
Journal:  J Biosci       Date:  2019-06       Impact factor: 1.826

2.  Lgl reduces endosomal vesicle acidification and Notch signaling by promoting the interaction between Vap33 and the V-ATPase complex.

Authors:  Marta Portela; Liu Yang; Sayantanee Paul; Xia Li; Alexey Veraksa; Linda M Parsons; Helena E Richardson
Journal:  Sci Signal       Date:  2018-06-05       Impact factor: 8.192

Review 3.  Tumour-host interactions through the lens of Drosophila.

Authors:  David Bilder; Katy Ong; Tsai-Ching Hsi; Kavya Adiga; Jung Kim
Journal:  Nat Rev Cancer       Date:  2021-08-13       Impact factor: 60.716

4.  miR-9a mediates the role of Lethal giant larvae as an epithelial growth inhibitor in Drosophila.

Authors:  Scott G Daniel; Atlantis D Russ; Kathryn M Guthridge; Ammad I Raina; Patricia S Estes; Linda M Parsons; Helena E Richardson; Joyce A Schroeder; Daniela C Zarnescu
Journal:  Biol Open       Date:  2018-01-26       Impact factor: 2.422

5.  Notch signals modulate lgl mediated tumorigenesis by the activation of JNK signaling.

Authors:  Maimuna Sali Paul; Ankita Singh; Debdeep Dutta; Mousumi Mutsuddi; Ashim Mukherjee
Journal:  BMC Res Notes       Date:  2018-04-16

6.  Human Cancer Cells Signal Their Competitive Fitness Through MYC Activity.

Authors:  Simone Di Giacomo; Manuela Sollazzo; Dario de Biase; Moira Ragazzi; Paola Bellosta; Annalisa Pession; Daniela Grifoni
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

Review 7.  Modelling Cooperative Tumorigenesis in Drosophila.

Authors:  Helena E Richardson; Marta Portela
Journal:  Biomed Res Int       Date:  2018-03-06       Impact factor: 3.411

8.  [MiR-665 Promotes the Biological Behavior of Small Cell Lung Cancer by Targeting LLGL1].

Authors:  Rongfeng Liu; Lingling Zhang; Zhihong Xu; Yanzhi Cui
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.